Gene expression control by glucocorticoid receptors during innate immune responses

Frontiers in Endocrinology

Volumn 7, Issue APR, 2016, Pages

  Xavier, Andre Machado ^a   Anunciato, Aparecida Kataryna Olimpio ^a   Rosenstock, Tatiana Rosado ^b   Glezer, Isaias ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Santa Casa de Sao Paulo Medical School   (Brazil)

Author keywords

Acute phase response; Cortisol; Gene expression; GRE; Inflammatory diseases; Innate immune response; SEGRAs; Transrepression

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DNA BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PENTRAXIN 3; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

EID: 84964917516     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00031     Document Type: Short Survey

References (80)

1. Hartman FA, Scott WJ. Protection of adrenalectomized animals against bacterial intoxication by an extract of the adrenal cortex. J Exp Med (1932) 55:63-9. doi:10.1084/jem.55.1.63
2. Selye H. On the hormonal activity of a steroid compound. Science (1941) 94:94. doi:10.1126/science.94.2430.94
3. Flower RJ. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol (1988) 94:987-1015. doi:10.1111/j.1476-5381.1988.tb11614.x
4. de Herder WW. Heroes in endocrinology: Nobel Prizes. Endocr Connect (2014) 3:R94-104. doi:10.1530/EC-14-0070
5. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature (1979) 278:456-9. doi:10.1038/278456a0
6. Russo-Marie F, Paing M, Duval D. Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J Biol Chem (1979) 254:8498-504
7. Tsurufuji S, Sugio K, Takemasa F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature (1979) 280:408-10. doi:10.1038/280408a0
8. Gustafsson J-A. Historical overview of nuclear receptors. J Steroid Biochem Mol Biol (2015) 157:3-6. doi:10.1016/j.jsbmb.2015.03.004
9. Lucibello FC, Slater EP, Jooss KU, Beato M, Müller R. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J (1990) 9:2827-34
10. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A (1994) 91:752-6. doi:10.1073/pnas.91.2.752
11. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol (1995) 15:943-53. doi:10.1128/MCB.15.2.943
12. Sundahl N, Bridelance J, Libert C, De Bosscher K, Beck IM. Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds. Pharmacol Ther (2015) 152:28-41. doi:10.1016/j.pharmthera.2015.05.001
13. Hu X, Chen J, Wang L, Ivashkiv LB. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol (2007) 82:237-43. doi:10.1189/jlb.1206763
14. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol (2014) 14:36-49. doi:10.1038/nri3581
15. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol (2011) 12:695-708. doi:10.1038/ni.2065
16. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem (2007) 282:20059-63. doi:10.1074/jbc. R700016200
17. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev (1998) 19:269-301. doi:10.1210/edrv.19.3.0331
18. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2010) 75:1-12. doi:10.1016/j.steroids.2009.09.002
19. Lu NZ, Cidlowski JA. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol (2006) 16:301-7. doi:10.1016/j.tcb.2006.04.005
20. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol (2006) 102:11-21. doi:10.1016/j.jsbmb.2006.09.009
21. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids (2005) 70:407-17. doi:10.1016/j.steroids.2005.02.006
22. Stallcup MR, Kim JH, Teyssier C, Lee Y-H, Ma H, Chen D. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J Steroid Biochem Mol Biol (2003) 85:139-45. doi:10.1016/S0960-0760(03)00222-X
23. York B, O'Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem (2010) 285:38743-50. doi:10.1074/jbc. R110.193367
24. Auboeuf D, Hönig A, Berget SM, O'Malley BW. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science (2002) 298:416-9. doi:10.1126/science.1073734
25. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell (2002) 108:465-74. doi:10.1016/S0092-8674(02)00641-4
26. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev (1999) 20:321-44. doi:10.1210/edrv.20.3.0366
27. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol (1999) 69:3-12. doi:10.1016/S0960-0760(98)00144-7
28. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell (1990) 62:1189-204. doi:10.1016/0092-8674(90)90395-U
29. Kino T, Chrousos GP. Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance. J Allergy Clin Immunol (2002) 109:609-13. doi:10.1067/mai.2002.123708
30. Göttlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med (Berl) (1998) 76:480-9. doi:10.1007/s001090050242
31. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell (2011) 145:224-41. doi:10.1016/j.cell.2011.03.027
32. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science (1990) 249:1266-72. doi:10.1126/science.2119054
33. Hoeppner MA, Mordacq JC, Linzer DI. Role of the composite glucocorticoid response element in proliferin gene expression. Gene Expr (1995) 5:133-41
34. Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci (2004) 1024:86-101. doi:10.1196/annals.1321.007
35. Orti E, Hu LM, Munck A. Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J Biol Chem (1993) 268:7779-84
36. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med (2006) 203:7-13. doi:10.1084/jem.20050466
37. Kleiman A, Tuckermann JP. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol Cell Endocrinol (2007) 275:98-108. doi:10.1016/j.mce.2007.05.009
38. De Bosscher K, Vanden Berghe W, Beck IM, Van Molle W, Hennuyer N, Hapgood J, et al. A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci U S A (2005) 102:15827-32. doi:10.1073/pnas.0505554102
39. Newton R, Holden NS. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol (2007) 72:799-809. doi:10.1124/mol.107.038794
40. Joshi T, Johnson M, Newton R, Giembycz M. An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics. Br J Pharmacol (2015) 172:1360-78. doi:10.1111/bph.13014
41. Ayroldi E, Cannarile L, Migliorati G, Nocentini G, Delfino DV, Riccardi C. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J (2012) 26:4805-20. doi:10.1096/fj.12-216382
42. Schoneveld JLM, Fritsch-Stork RD, Bijlsma JWJ. Nongenomic glucocorticoid signaling: new targets for immunosuppressive therapy? Arthritis Rheum (2011) 63:3665-7. doi:10.1002/art.30635
43. Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci (2013) 34:518-30. doi:10.1016/j.tips.2013.07.003
44. Smallie T, Ross EA, Ammit AJ, Cunliffe HE, Tang T, Rosner DR, et al. Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide. J Immunol (2015) 195:277-88. doi:10.4049/jimmunol.1402830
45. Ronchetti S, Migliorati G, Riccardi C. GILZ as a mediator of the anti-inflammatory effects of glucocorticoids. Front Endocrinol (2015) 6:170. doi:10.3389/fendo.2015.00170
46. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell (2013) 49:158-71. doi:10.1016/j.molcel.2012.10.013
47. Chinenov Y, Gupte R, Rogatsky I. Nuclear receptors in inflammation control: repression by GR and beyond. Mol Cell Endocrinol (2013) 380:55-64. doi:10.1016/j.mce.2013.04.006
48. Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol (2010) 10:365-76. doi:10.1038/nri2748
49. Miyata M, Lee J-Y, Susuki-Miyata S, Wang WY, Xu H, Kai H, et al. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nat Commun (2015) 6:6062. doi:10.1038/ncomms7062
50. Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, et al. Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J (2008) 27:1682-93. doi:10.1038/emboj.2008.95
51. Chinenov Y, Sacta MA, Cruz AR, Rogatsky I. GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. Proc Natl Acad Sci U S A (2008) 105:20185-90. doi:10.1073/pnas.0810863105
52. Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, Ivashkiv LB, et al. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol (2010) 30:4564-74. doi:10.1128/MCB.00146-10
53. Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J (2006) 25:108-17. doi:10.1038/sj.emboj.7600919
54. King EM, Chivers JE, Rider CF, Minnich A, Giembycz MA, Newton R. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation-and transrepression-dependent mechanisms. PLoS One (2013) 8:e53936. doi:10.1371/journal.pone.0053936
55. Beck IM, Van Crombruggen K, Holtappels G, Daubeuf F, Frossard N, Bachert C, et al. Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue. PLoS One (2015) 10:e0123068. doi:10.1371/journal.pone.0123068
56. Schäcke H, Schottelius A, Döcke W-D, Strehlke P, Jaroch S, Schmees N, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A (2004) 101:227-32. doi:10.1073/pnas.0300372101
57. van Lierop MJC, Alkema W, Laskewitz AJ, Dijkema R, van der Maaden HM, Smit MJ, et al. Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index. PLoS One (2012) 7:e48385. doi:10.1371/journal.pone.0048385
58. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev (2000) 21:55-89. doi:10.1210/er.21.1.55
59. Glezer I, Chernomoretz A, David S, Plante MM, Rivest S. Genes involved in the balance between neuronal survival and death during inflammation. PLoS One (2007) 2:e310. doi:10.1371/journal.pone.0000310
60. Langlais D, Couture C, Balsalobre A, Drouin J. Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response. PLoS Genet (2008) 4:e1000224. doi:10.1371/journal.pgen.1000224
61. Lannan EA, Galliher-Beckley AJ, Scoltock AB, Cidlowski JA. Proinflammatory actions of glucocorticoids: glucocorticoids and TNFa coregulate gene expression in vitro and in vivo. Endocrinology (2012) 153:3701-12. doi:10.1210/en.2012-1020
62. Vizzardelli C, Pavelka N, Luchini A, Zanoni I, Bendickson L, Pelizzola M, et al. Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur J Immunol (2006) 36:1504-15. doi:10.1002/eji.200535488
63. Yamazaki S, Akira S, Sumimoto H. Glucocorticoid augments lipopolysaccharide-induced activation of the IkappaBzeta-dependent genes encoding the anti-microbial glycoproteins lipocalin 2 and pentraxin 3. J Biochem (2015) 157:399-410. doi:10.1093/jb/mvu086
64. Smith AD, Datta SP, Smith GH, Campbell PN, Bentley R, McKenzie H, et al. Oxford Dictionary of Biochemistry and Molecular Biology. Oxford: Oxford University Press (1997)
65. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 340:448-54. doi:10.1056/NEJM199902113400607
66. Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, et al. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J (2013) 27:1176-90. doi:10.1096/fj.12-222257
67. Warszawska JM, Gawish R, Sharif O, Sigel S, Doninger B, Lakovits K, et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest (2013) 123:3363-72. doi:10.1172/Jci67911
68. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol (2008) 22:1416-26. doi:10.1210/me.2007-0420
69. Vilahur G, Badimon L. Biological actions of pentraxins. Vascul Pharmacol (2015) 73:38-44. doi:10.1016/j.vph.2015.05.001
70. Glezer I, Rivest S. Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites. Brain Behav Immun (2010) 24:695-704. doi:10.1016/j.bbi.2010.01.005
71. Le GoffB, Singbrant S, Tonkin BA, Martin TJ, Romas E, Sims NA, et al. Onostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts. Cytokine (2014) 68:101-9. doi:10.1016/j.cyto.2014.04.001
72. Flammer JR, Rogatsky I. Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol (2011) 25:1075-86. doi:10.1210/me.2011-0068
73. Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab (2013) 24:109-19. doi:10.1016/j.tem.2012.11.005
74. Lim H-Y, Müller N, Herold MJ, Van Den Brandt J, Reichardt HM. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology (2007) 122:47-53. doi:10.1111/j.1365-2567.2007.02611.x
75. Hodrea J, Majai G, Doró Z, Zahuczky G, Pap A, Rajnavölgyi É, et al. The glucocorticoid dexamethasone programs human dendritic cells for enhanced phagocytosis of apoptotic neutrophils and inflammatory response. J Leukoc Biol (2012) 91:127-36. doi:10.1189/jlb.0511243
76. Vago JP, Nogueira CRC, Tavares LP, Soriani FM, Lopes F, Russo RC, et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol (2012) 92:249-58. doi:10.1189/jlb.0112008
77. Weber PSD. Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils. J Leukoc Biol (2003) 75:815-27. doi:10.1189/jlb.1003505
78. Pazdrak K, Moon Y, Straub C, Stafford S, Kurosky A. Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. Apoptosis (2016) 21:421-31. doi:10.1007/s10495-016-1226-5
79. Schiller BJ, Chodankar R, Watson LC, Stallcup MR, Yamamoto KR. Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol (2014) 15:418. doi:10.1186/PREACCEPT-2066059439130185
80. Dejager L, Vandevyver S, Petta I, Libert C. Dominance of the strongest: inflammatory cytokines versus glucocorticoids. Cytokine Growth Factor Rev (2014) 25:21-33. doi:10.1016/j.cytogfr.2013.12.006